General Information of the Compound
Compound ID
CP0202330
Compound Name
1-([1,3]oxazolo[4,5-b]pyridin-2-yl)octan-1-one
    Show/Hide
Synonyms
1-(oxazolo[4,5-b]pyridin-2-yl)octan-1-one
BDBM50350545
CHEMBL257305
SCHEMBL3966136
    Show/Hide
Structure
Formula
C14H18N2O2
Molecular Weight
246.31
Canonical SMILES
CCCCCCCC(=O)c1nc2ncccc2o1
    Show/Hide
InChI
InChI=1S/C14H18N2O2/c1-2-3-4-5-6-8-11(17)14-16-13-12(18-14)9-7-10-15-13/h7,9-10H,2-6,8H2,1H3
    Show/Hide
InChIKey
HTWHWGPGIJSJQP-UHFFFAOYSA-N
Physicochemical Property
logP
3.766
Rotatable Bonds
7
Heavy Atom Count
18
Polar Areas
55.99
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
4
Complexity
18

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 22486174
ChEMBL ID
CHEMBL257305
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04933, Diacylglycerol lipase-alpha
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000025 HEK-293T Homo sapiens (Human)  1
1
IC50 = 630.96 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( 1-(oxazolo[4,5-b]pyridin-2-yl)octan-1-one )
Drug Name 1-(oxazolo[4,5-b]pyridin-2-yl)octan-1-one